Top Financings of the Week

The Recap

The best information on capital raises and financing activity in under 5 minutes:

• Take-Two Interactive Software Inc. (NASDAQ:TTWO) Leading game publisher, creating games through Rockstar Games, 2K and more announced its offer to raise ~$1.0 billion by the sale of 4.75 million new shares at $225 per share in a public offering. 

• Sable Offshore Corp. (NYSE: SOC) Offshore energy company closed its upsized public offering of 10,000,000 shares at $29.50 each, including full exercise of the underwriters’ option, for gross proceeds of ~$295 million.

• Outlook Therapeutics, Inc. (NASDAQ: OTLK) Retina-focused biotech priced a public offering of 9.29M shares and accompanying warrants to purchase 18.57M shares at a combined price of $1.40 for $13 million.

Take-Two is a leading developer, publisher, and marketer of interactive entertainment for consumers around the globe. The Company develops and publishes products principally through Rockstar Games, 2K and Zynga.

The Company announced a financing for approximately $1.04 billion, which is intended to be used for general corporate purposes, which may include the repayment of outstanding debt and future acquisitions.

If the underwriters exercise their option in full, the expected net proceeds of the offering after expenses would be approximately $1.19 billion.

Sable Offshore is an independent oil and gas company, headquartered in Houston, Texas, focused on responsibly developing the Santa Ynez Unit in federal waters offshore California.

The Company recently closed its upsized public offering of 10,000,000 shares at $29.50 each, including full exercise of the underwriters’ option, for gross proceeds of ~$295 million.

The Company intends to use net proceeds of the offering for capital expenditures, working capital purposes and general corporate purposes.

Outlook Therapeutics is a biopharmaceutical company focused on the development and commercialization of ONS-5010/LYTENAVA™ to enhance the standard of care for the treatment of retina diseases.

The Company recently announced pricing for its public offering of 9.29M shares and accompanying warrants to purchase 18.57M shares at a combined price of $1.40 for $13 million.

Outlook intends to use the net proceeds from the offering for working capital and other general corporate purposes.

Top Money Moves

Lead Investors

• Guanghui Energy: $860,597,143 | Energy | Lead Investor: Funde Sino Life

• Warby Parker: $75,000,000 | E-Commerce | Lead Investor: Google

• Luminar: $35,000,000 | Automotive | Lead Investor: Yorkville Advisors

• GENFIT: $29,817,293 | Biopharma | Lead Investor: Ipsen

• NFiniTi: $20,000,000 | Brewing | Lead Investor: RH2 Equity Partners

• Canyon Resources: $15,814,165 | Mining | Lead Investor: Fortuna Holdings

• Ontrak: $10,000,000 | Health Care | Lead Investor: Acuitas Capital

• Telomir Pharmaceuticals: $3,000,000 | Biotechnology | Lead Investor: Bayshore Capital

• Getchell Gold: $2,911,950 | Industrial | Lead Investor: Myrmikan Capital

• Satellos Bioscience: $1,146,487 | Health Care | Lead Investor: Bloom Burton & Co.

Do you know of any other lead investors who put capital into the markets this week? We would be happy to feature the transactions, send us an email at [email protected]